← Leaderboards
Edward P Feener
Joslin Diabetes Center
$7,050,839
Attributed
$7,050,839
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $777.1K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$7,050,839 · 6
By mechanism
R01$6,224,942 · 3
P30$591,897 · 2
S10$234,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Joslin Diabetes Center
Same institution · by research overlap
- Fabricio Simao$1,075,256
- Susan Bonner-Weir$9,968,376
- Lloyd P Aiello$1,714,136
- Christian Rask-Madsen$1,402,866
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusProteomicsBaseBradykininPathway InteractionsReportingResponseHemorrhagePlasma KallikreinRodent ModelVascular PermeabilitiesGrantMediatingBlood VesselsAreaEdemaNamesTechnologyProteinsMedicineDiabeticBradykinin ReceptorMacular EdemaInjection Of Therapeutic Agent
Grant awards (25)
Role of the kallikrein-kinin system in diabetic retinopathy$413,750
R01 · FY2016 · EY · contact PI
Role of the kallikrein-kinin system in diabetic retinopathy$405,475
R01 · FY2015 · EY · contact PI
Role of Hyperglycemia in Intracerebral Hemorrhage$366,693
R01 · FY2015 · NS · contact PI
Role of the kallikrein-kinin system in diabetic retinopathy$414,375
R01 · FY2014 · EY · contact PI
Role of Hyperglycemia in Intracerebral Hemorrhage$362,725
R01 · FY2014 · NS · contact PI
Role of Hyperglycemia in Intracerebral Hemorrhage$352,531
R01 · FY2013 · NS · contact PI
Role of the kallikrein-kinin system in diabetic retinopathy$379,383
R01 · FY2012 · EY · contact PI
Role of Hyperglycemia in Intracerebral Hemorrhage$379,366
R01 · FY2012 · NS · contact PI
Role of the kallikrein-kinin system in diabetic retinopathy$379,497
R01 · FY2011 · EY · contact PI
PROTEOMICS CORE$117,835
P30 · FY2011 · DK · contact PI
Role of the kallikrein-kinin system in diabetic retinopathy$395,425
R01 · FY2010 · EY · contact PI
PROTEOMICS CORE$133,310
P30 · FY2010 · DK · contact PI
Role of the kallikrein-kinin system in diabetic retinopathy$399,617
R01 · FY2009 · EY · contact PI
Role of the kallikrein-kinin system in diabetic retinopathy$237,292
R01 · FY2009 · EY · contact PI
PROTEOMICS CORE$121,759
P30 · FY2009 · DK · contact PI
Role of the kallikrein-kinin system in diabetic retinopathy$375,712
R01 · FY2008 · EY · contact PI
PROTEOMICS CORE$118,635
P30 · FY2008 · DK · contact PI
PROTEOMICS CORE$100,358
P30 · FY2007 · DK · contact PI
Regulation of angiotensin-induced PAI-1 expression$264,255
R01 · FY2006 · DK · contact PI
Regulation of angiotensin-induced PAI-1 expression$270,614
R01 · FY2005 · DK
Regulation of angiotensin-induced PAI-1 expression$270,614
R01 · FY2004 · DK
Regulation of angiotensin-induced PAI-1 expression$270,614
R01 · FY2003 · DK
Axima-CFR MALDI TOF Mass Spectrometer$234,000
S10 · FY2003 · RR
Regulation of angiotensin-induced PAI-1 expression$287,004
R01 · FY2002 · DK
Core--Media$0
P30 · FY2002 · DK